Abeona 治疗公司
US ˙ NasdaqCM ˙ US00289Y2063

介绍

本页面提供了有关 Oracle Partners Lp 已知的内部交易历史的全面分析。内部人士包括公司的高管、董事或重要投资者。一般而言，基于内幕、非公开信息进行交易是非法的。这并不意味着他们在自己的公司进行任何交易都是非法的。但是，他们必须通过Form 4向美国证券交易委员会（SEC）报告所有交易。尽管存在这些限制，学术研究表明，整体而言，内部人士在自己公司中的投资表现往往优于市场。

平均交易盈利能力

“平均交易盈利能力”衡量了内部人士在过去三年中所有非计划性的公开市场买入交易的平均回报率。计算过程包括检查每笔交易，排除了作为10b5-1交易计划的一部分的交易。然后，对每笔交易在3、6和12个月的表现进行平均，以生成该笔交易最终的表现指标。然后，将所有交易的表现指标进行平均，计算出内部人士的总体平均表现指标。列表仅包含在过去两年中进行过至少三笔交易的内部人士。

如果内部人士的交易盈利能力显示为"N/A"，则可能是因为该内部人士在过去三年内没有进行任何公开市场买入交易，或者他们进行的交易距离现在时间太近，无法计算出可靠的表现指标。

更新频率：每日

查看收益最高的的内幕交易者列表。

查看排名最高的内部人士。
报告内部持仓的公司

美国证券交易委员会（SEC）文件显示Oracle Partners Lp已报告在以下公司拥有持仓或进行了交易：

证券 职位 最新报告的持仓
US:MOTS / Motus GI Holdings, Inc. 0
US:BIOL / BIOLASE, Inc. 10% Owner 0
US:VRML / Vermillion, Inc. 10% Owner 0
US:SLNO / Soleno Therapeutics, Inc. 10% Owner 655,000
US:HNSN / Hansen Medical, Inc. 10% Owner 0
US:ACCP / 10% Owner 247,651
如何解读这些图表

以下图表显示了在Oracle Partners Lp进行的每笔公开市场非计划交易后证券的股价表现。非计划交易是指没有作为10b5-1交易计划的一部分而进行的交易。股价表现以累积百分比变化的方式绘制。例如，如果一笔内部人士交易是在2019年1月1日进行的，该图表将显示该证券的每日百分比变化直至当前日期。如果在此期间股价从10美元涨至15美元，则股价的累积百分比变化将为50%。从10美元涨至20美元的价格变化将为100%，而从10美元跌至5美元的价格变化将为-50%。

最终，我们将评估内部人士的交易与股价的超额回报（正向或负向）之间的相关性，以判断内部人士是否在交易中利用内部信息获利。如果内部人士有这样的行为，我们预期看到（a）买入后的正回报，或者（b）卖出后的负回报。对于情况（a），买入图表将显示一系列向上倾斜的曲线，表示每次买入后都有正回报。对于情况（b），卖出图表将显示一系列向下倾斜的曲线，表示每次卖出后都有负回报。

然而，仅凭这一点还不足以得出结论。例如，如果公司的股价在多年内呈现非周期性上升，我们会预期所有买入后的图表都呈现向上倾斜。同样地，多年来呈现非周期性下降的股价会导致卖出后的图表也呈现向下倾斜。这两种情况的图表都不能表示内部人士在进行内幕交易。

最有力的指标是在公司股价呈极度循环波动的情况下，“买入”图表显示正向信号，而“卖出”图表显示负向趋势。这种情况强烈暗示内部人士可能根据内幕信息精确地计时进行交易，以获得财务优势。

ABEO / Abeona Therapeutics Inc.内部人士买入 - 短期收益分析

在这一部分，我们分析了在 ABEO / Abeona Therapeutics Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报，以及是否值得跟踪。该分析基于每笔交易后一年的情况，结果仅为理论值。

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最高利润的
天数		 达到最高利润时的
价格		 最高
利润($)		 最高回报率（%）
2008-02-12 ACCP FEINBERG LARRY N 29,736 3.1500 29,736 3.1500 93,668 731
2007-06-19 ACCP FEINBERG LARRY N 60,000 5.1700 60,000 5.1700 310,200
2007-01-22 ACCP FEINBERG LARRY N 6,040 2.5300 6,040 2.5300 15,281
2005-12-31 ACCP FEINBERG LARRY N 15,636 0.6500 15,636 0.6500 10,163
2005-12-31 ACCP FEINBERG LARRY N 82,745 0.6500 82,745 0.6500 53,784
2005-12-31 ACCP FEINBERG LARRY N 299,056 0.6500 299,056 0.6500 194,386
2005-12-31 ACCP FEINBERG LARRY N 78,184 0.6500 78,184 0.6500 50,820
2005-02-01 ACCP FEINBERG LARRY N 30,200 2.6900 30,200 2.6900 81,238

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

ABEO / Abeona Therapeutics Inc. Insider Trades
ABEO / Abeona Therapeutics Inc.内部人士卖出 - 短期亏损分析

在这一部分，我们分析了在 ABEO / Abeona Therapeutics Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式，可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况，

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最低利润的
天数		 达到最低利润时的
价格		 避免的
最高损失金额($)		 避免的
最高损失率($)
2008-02-12 ACCP FEINBERG LARRY N 29,736 3.1500 29,736 3.1500 93,668 731
2007-07-24 ACCP FEINBERG LARRY N 2,040 4.3500 2,040 4.3500 8,874
2007-07-23 ACCP FEINBERG LARRY N 4,000 4.3563 4,000 4.3563 17,425
2007-06-19 ACCP FEINBERG LARRY N 40,000 5.1700 40,000 5.1700 206,800
2007-06-19 ACCP FEINBERG LARRY N 20,000 5.1700 20,000 5.1700 103,400
2007-03-01 ACCP FEINBERG LARRY N 1,200 7.1250 1,200 7.1250 8,550
2007-02-28 ACCP FEINBERG LARRY N 10,000 7.1000 10,000 7.1000 71,000
2007-02-28 ACCP FEINBERG LARRY N 4,500 7.1000 4,500 7.1000 31,950
2007-02-27 ACCP FEINBERG LARRY N 300 7.0000 300 7.0000 2,100
2007-02-27 ACCP FEINBERG LARRY N 100 7.0000 100 7.0000 700
2007-02-26 ACCP FEINBERG LARRY N 19,000 7.3140 19,000 7.3140 138,966
2007-02-26 ACCP FEINBERG LARRY N 5,000 7.3140 5,000 7.3140 36,570
2007-02-26 ACCP FEINBERG LARRY N 1,000 7.3140 1,000 7.3140 7,314
2007-01-22 ACCP FEINBERG LARRY N 6,040 2.5300 6,040 2.5300 15,281
2006-09-01 ACCP FEINBERG LARRY N 1 1
2006-09-01 ACCP FEINBERG LARRY N 0 0
2006-09-01 ACCP FEINBERG LARRY N 0 0
2005-02-01 ACCP FEINBERG LARRY N 30,200 2.6900 30,200 2.6900 81,238

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

ABEO / Abeona Therapeutics Inc. Insider Trades
AWHL / Aspira Women's Health Inc.内部人士买入 - 短期收益分析

在这一部分，我们分析了在 ABEO / Abeona Therapeutics Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报，以及是否值得跟踪。该分析基于每笔交易后一年的情况，结果仅为理论值。

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最高利润的
天数		 达到最高利润时的
价格		 最高
利润($)		 最高回报率（%）
2017-02-17 VRML FEINBERG LARRY N 617,731 1.4000 617,731 1.4000 864,823 304
2015-07-14 VRML FEINBERG LARRY N 510,204 1.9600 510,204 1.9600 1,000,000
2015-07-14 VRML FEINBERG LARRY N 1,839 1.9054 1,839 1.9054 3,504
2014-12-23 VRML FEINBERG LARRY N 972,222 1.4400 972,222 1.4400 1,400,000

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

AWHL / Aspira Women's Health Inc. Insider Trades
AWHL / Aspira Women's Health Inc.内部人士卖出 - 短期亏损分析

在这一部分，我们分析了在 ABEO / Abeona Therapeutics Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式，可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况，

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最低利润的
天数		 达到最低利润时的
价格		 避免的
最高损失金额($)		 避免的
最高损失率($)
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

AWHL / Aspira Women's Health Inc. Insider Trades
SLNO / Soleno Therapeutics, Inc.内部人士买入 - 短期收益分析

在这一部分，我们分析了在 ABEO / Abeona Therapeutics Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报，以及是否值得跟踪。该分析基于每笔交易后一年的情况，结果仅为理论值。

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最高利润的
天数		 达到最高利润时的
价格		 最高
利润($)		 最高回报率（%）
2019-07-26 SLNO FEINBERG LARRY N 49,569 2.1426 3,305 32.1390 106,207 300 4.2300 -92,230 -86.84
2019-07-26 SLNO FEINBERG LARRY N 7,500 2.1426 500 32.1390 16,070
2019-03-14 SLNO FEINBERG LARRY N 900 1.1995 60 17.9925 1,080
2019-03-14 SLNO FEINBERG LARRY N 95,235 1.2229 6,349 18.3435 116,463
2019-03-14 SLNO FEINBERG LARRY N 192 1.1995 13 17.9925 230
2019-03-14 SLNO FEINBERG LARRY N 20,360 1.2229 1,357 18.3435 24,898
2019-03-14 SLNO FEINBERG LARRY N 128 1.1995 9 17.9925 154
2019-03-14 SLNO FEINBERG LARRY N 13,548 1.2229 903 18.3435 16,568
2018-05-15 SLNO FEINBERG LARRY N 1,218 1.9276 81 28.9140 2,348
2018-05-15 SLNO FEINBERG LARRY N 256 1.9276 17 28.9140 493
2018-05-14 SLNO FEINBERG LARRY N 40,100 1.7916 2,673 26.8740 71,843
2018-05-14 SLNO FEINBERG LARRY N 8,426 1.7916 562 26.8740 15,096

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

SLNO / Soleno Therapeutics, Inc. Insider Trades
SLNO / Soleno Therapeutics, Inc.内部人士卖出 - 短期亏损分析

在这一部分，我们分析了在 ABEO / Abeona Therapeutics Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式，可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况，

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最低利润的
天数		 达到最低利润时的
价格		 避免的
最高损失金额($)		 避免的
最高损失率($)
2020-06-08 SLNO FEINBERG LARRY N 150,918 3.4012 10,061 51.0180 513,302 339 0.9662 -503,581 -98.11
2020-06-05 SLNO FEINBERG LARRY N 49,325 3.3366 3,288 50.0490 164,578

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

SLNO / Soleno Therapeutics, Inc. Insider Trades
内幕交易历史

该表格显示了由 Oracle Partners Lp 进行的所有内幕交易的完整列表，这些交易已向美国证券交易委员会（SEC）披露。

备案日期 交易日期 表格 股票代码 证券 代码 10b5-1 股数 剩余股数 %
变化		 每股
股价		 交易
金额		 剩余
金额
2021-02-05 2021-01-26 4 MOTS Motus GI Holdings, Inc.
Common Stock 		S - Sale -30,000 0 -100.00 1.90 -57,000
2021-02-05 2021-01-26 4 MOTS Motus GI Holdings, Inc.
Common Stock 		S - Sale -29,115 105,885 -21.57 1.90 -55,417 201,542
2020-06-10 2020-06-09 4 BIOL BIOLASE, INC
Common Stock 		S - Sale -10,400 0 -100.00 0.55 -5,728
2020-06-10 2020-06-09 4 BIOL BIOLASE, INC
Common Stock 		S - Sale -47,885 0 -100.00 0.55 -26,270
2020-06-10 2020-06-09 4 BIOL BIOLASE, INC
Common Stock 		S - Sale -79,841 184,300 -30.23 0.55 -44,024 101,623
2020-06-10 2020-06-09 4 BIOL BIOLASE, INC
Common Stock 		S - Sale -435,596 278,300 -61.02 0.55 -240,188 153,455
2020-06-10 2020-06-09 4 BIOL BIOLASE, INC
Common Stock 		S - Sale -1,196,590 1,276,500 -48.38 0.55 -659,800 703,862
2020-06-10 2020-06-08 4 BIOL BIOLASE, INC
Common Stock 		S - Sale -358,744 264,141 -57.59 0.55 -198,816 146,387
2020-06-10 2020-06-08 4 BIOL BIOLASE, INC
Common Stock 		S - Sale -564,738 713,896 -44.17 0.55 -312,978 395,641
2020-06-10 2020-06-08 4 BIOL BIOLASE, INC
Common Stock, par value $0.001 per share ("Common Stock") 		S - Sale -2,479,456 2,473,090 -50.06 0.55 -1,374,115 1,370,586
2020-06-10 2020-06-08 4 VRML Aspira Women's Health Inc.
Warrants to acquire Common Stock 		X - Other -463,298 0 -100.00
2020-06-10 2020-06-08 4 VRML Aspira Women's Health Inc.
Common Stock 		X - Other 463,298 6,137,052 8.17 1.80 833,936 11,046,694
2020-06-09 2020-06-08 4 SLNO SOLENO THERAPEUTICS INC
Common Stock 		S - Sale -150,918 655,000 -18.73 3.40 -513,302 2,227,786
2020-06-09 2020-06-05 4 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share ("Common Stock") 		S - Sale -49,325 805,918 -5.77 3.34 -164,578 2,689,026
2019-10-31 2019-10-29 4 BIOL BIOLASE, INC
Series E Preferred Stock 		P - Purchase 1,843 1,843 57.50 105,972 105,972
2019-10-31 2019-10-29 4 BIOL BIOLASE, INC
Series E Preferred Stock 		P - Purchase 2,783 2,783 57.50 160,022 160,022
2019-10-31 2019-10-29 4 BIOL BIOLASE, INC
Series E Preferred Stock 		P - Purchase 12,765 12,765 57.50 733,988 733,988
2019-07-30 2019-07-26 4 SLNO SOLENO THERAPEUTICS INC
Common Stock 		P - Purchase 7,500 350,334 2.19 2.14 16,070 750,626
2019-07-30 2019-07-26 4 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share ("Common Stock") 		P - Purchase 49,569 2,665,050 1.90 2.14 106,207 5,710,136
2019-07-01 2019-07-01 4 MOTS Motus GI Holdings, Inc.
Common Stock 		P - Purchase 5,000 30,000 20.00 2.99 14,948 89,688
2019-07-01 2019-07-01 4 MOTS Motus GI Holdings, Inc.
Common Stock 		P - Purchase 35,000 135,000 35.00 3.02 105,553 407,133
2019-07-01 2019-06-27 4 MOTS Motus GI Holdings, Inc.
Common Stock 		P - Purchase 25,000 25,000 3.00 75,000 75,000
2019-07-01 2019-06-27 4 MOTS Motus GI Holdings, Inc.
Common Stock 		P - Purchase 100,000 100,000 3.00 300,000 300,000
2019-07-01 2019-06-27 4 MOTS Motus GI Holdings, Inc.
Common Stock 		P - Purchase 138,698 550,698 33.66 3.00 416,094 1,652,094
2019-07-01 2019-06-27 4 MOTS Motus GI Holdings, Inc.
Common Stock 		P - Purchase 93,566 379,566 32.72 3.00 280,698 1,138,698
2019-07-01 2019-06-27 4 MOTS Motus GI Holdings, Inc.
Common Stock, par value $0.0001 per share ("Common Stock") 		P - Purchase 634,402 2,711,402 30.54 3.00 1,903,206 8,134,206
2019-06-27 2019-06-25 4 BIOL BIOLASE, INC
Common Stock 		S - Sale -227,155 438,585 -34.12 1.50 -340,732 657,878
2019-06-27 2019-06-25 4 BIOL BIOLASE, INC
Common Stock 		S - Sale -263,845 1,000,334 -20.87 1.50 -395,768 1,500,501
2019-06-27 2019-06-25 4 BIOL BIOLASE, INC
Common Stock, par value $0.001 per share ("Common Stock") 		S - Sale -509,000 3,676,046 -12.16 1.50 -763,500 5,514,069
2019-03-18 2019-03-14 4 SLNO SOLENO THERAPEUTICS INC
Common Stock 		P - Purchase 13,548 342,834 4.11 1.22 16,568 419,252
2019-03-18 2019-03-14 4 SLNO SOLENO THERAPEUTICS INC
Common Stock 		P - Purchase 128 329,286 0.04 1.20 154 394,979
2019-03-18 2019-03-14 4 SLNO SOLENO THERAPEUTICS INC
Common Stock 		P - Purchase 20,360 855,243 2.44 1.22 24,898 1,045,877
2019-03-18 2019-03-14 4 SLNO SOLENO THERAPEUTICS INC
Common Stock 		P - Purchase 192 834,883 0.02 1.20 230 1,001,442
2019-03-18 2019-03-14 4 SLNO SOLENO THERAPEUTICS INC
Common Stock 		P - Purchase 95,235 2,615,481 3.78 1.22 116,463 3,198,472
2019-03-18 2019-03-14 4 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share ("Common Stock") 		P - Purchase 900 2,520,246 0.04 1.20 1,080 3,023,035
2018-05-16 2018-05-15 4 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 		P - Purchase 256 551,423 0.05 1.93 493 1,062,923
2018-05-16 2018-05-15 4 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 		P - Purchase 1,218 1,669,541 0.07 1.93 2,348 3,218,207
2018-05-16 2018-05-14 4 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 		P - Purchase 8,426 551,167 1.55 1.79 15,096 987,471
2018-05-16 2018-05-14 4 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 		P - Purchase 40,100 1,668,323 2.46 1.79 71,843 2,988,967
2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 		4,016,283
2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 		2,605,156
2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 		2,930,801
2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 		4,016,283
2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 		2,605,156
2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 		2,930,801
2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 		4,016,283
2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 		2,605,156
2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 		2,930,801
2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 		4,016,283
2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 		2,605,156
2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 		2,930,801
2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 		4,016,283
2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 		2,605,156
2017-12-26 3 SLNO SOLENO THERAPEUTICS INC
Common Stock, par value $0.001 per share 		2,930,801
2017-12-06 2017-12-05 4 BIOL BIOLASE, INC
Common Stock 		P - Purchase 10,745,615 30,866,265 53.41 0.46 4,900,000 14,075,017
2017-12-06 2017-12-04 4 BIOL BIOLASE, INC
Common Stock 		P - Purchase 1,800,000 20,120,650 9.82 0.30 540,000 6,036,195
2017-08-31 2017-08-31 4 VRML VERMILLION, INC.
Warrants to acquire Common Stock 		X - Other -583,333 0 -100.00
2017-08-31 2017-08-31 4 VRML VERMILLION, INC.
Common Stock 		X - Other 583,333 9,825,289 6.31 1.00 583,333 9,825,289
2017-08-30 2017-08-25 4 VRML VERMILLION, INC.
Warrants to acquire Common Stock 		P - Purchase 583,333 583,333
2017-08-30 2017-08-25 4 VRML VERMILLION, INC.
Warrants to acquire Common Stock 		H - Other -583,333 0 -100.00
2017-07-05 2017-06-30 4 BIOL BIOLASE, INC
Warrants to acquire Common Stock 		P - Purchase 1,800,535 3,144,811 133.94 0.12 225,067 393,101
2017-07-05 2017-06-30 4 BIOL BIOLASE, INC
Series D Preferred Stock 		C - Conversion -36,986 0 -100.00
2017-07-05 2017-06-30 4 BIOL BIOLASE, INC
Common Stock 		C - Conversion 3,698,600 18,320,650 25.29 1.24 4,586,264 22,717,606
2017-02-17 2017-02-17 4 VRML VERMILLION, INC.
Warrant to acquire Common Stock 		P - Purchase 1 0 -100.00
2017-02-17 2017-02-17 4 VRML VERMILLION, INC.
Common Stock, par value $0.001 per share 		P - Purchase 617,731 9,825,289 6.71 1.40 864,823 13,755,405
2016-12-06 2016-12-05 4 BIOL BIOLASE, INC
Common Stock 		C - Conversion 46,463 14,608,464 0.32 1.85 85,957 27,025,658
2016-12-06 2016-12-02 4 BIOL BIOLASE, INC
Common Stock 		C - Conversion 53,537 14,562,001 0.37 1.78 95,296 25,920,362
2016-11-17 2016-11-16 4 BIOL BIOLASE, INC
Common Stock 		C - Conversion 33,674 14,508,464 0.23 1.71 57,583 24,809,473
2016-11-17 2016-11-15 4 BIOL BIOLASE, INC
Common Stock 		C - Conversion 18,514 14,478,326 0.13 1.72 31,844 24,902,721
2016-11-14 2016-11-14 4 BIOL BIOLASE, INC
Common Stock 		C - Conversion 33,674 14,459,812 0.23 1.61 54,215 23,280,297
2016-11-14 2016-11-11 4 BIOL BIOLASE, INC
Common Stock 		C - Conversion 48,513 14,426,138 0.34 1.81 87,809 26,111,310
2016-11-14 2016-11-10 4 BIOL BIOLASE, INC
Common Stock 		C - Conversion 42,000 14,377,625 0.29 1.81 76,020 26,023,501
2016-11-10 2016-11-09 4 BIOL BIOLASE, INC
Common Stock 		C - Conversion 125,000 14,335,625 0.88 1.70 212,500 24,370,562
2016-11-10 2016-11-08 4 BIOL BIOLASE, INC
Common Stock 		C - Conversion 2,000 14,230,625 0.01 1.52 3,040 21,630,550
2016-10-05 2016-09-30 4 BIOL BIOLASE, INC
Warrants to acquire Common Stock 		P - Purchase 850,797 2,194,983 63.29
2016-10-05 2016-09-30 4 BIOL BIOLASE, INC
Series C Preferred Stock 		C - Conversion -37,091 0 -100.00
2016-10-05 2016-09-30 4 BIOL BIOLASE, INC
Common Stock 		C - Conversion 3,699,100 14,228,625 35.13 1.13 4,179,983 16,078,346
2016-08-10 2016-08-08 4 BIOL BIOLASE, INC
Series C Preferred Stock 		P - Purchase 37,091 37,091 1.13 41,913 41,913
2016-08-10 2016-08-08 4 BIOL BIOLASE, INC
Warrants to acquire Common Stock 		P - Purchase 850,797 2,194,983 63.29 0.12 106,350 274,373
2016-07-29 2016-07-27 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share 		D - Sale to Issuer -22,659 0 -100.00 90,636.00 -2,053,721,124
2016-07-29 2016-07-27 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share 		D - Sale to Issuer -19,050 0 -100.00 76,200.00 -1,451,610,000
2016-07-29 2016-07-27 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share 		D - Sale to Issuer -3,950 0 -100.00 15,800.00 -62,410,000
2016-07-29 2016-07-27 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share 		D - Sale to Issuer -492,846 0 -100.00 1,971,384.00 -971,588,718,864
2016-07-29 2016-07-27 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share 		D - Sale to Issuer -854,377 0 -100.00 3,417,508.00 -2,919,840,232,516
2016-07-29 2016-07-27 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share 		D - Sale to Issuer -3,090,732 0 -100.00 12,362,928.00 -38,210,497,183,296
2015-07-16 2015-07-14 4 VRML VERMILLION, INC.
Common Stock, par value $0.001 per share 		P - Purchase 1,839 8,624,225 0.02 1.91 3,504 16,432,598
2015-07-16 2015-07-14 4 VRML VERMILLION, INC.
Common Stock, par value $0.001 per share 		P - Purchase 510,204 8,624,225 6.29 1.96 1,000,000 16,903,481
2015-05-14 2015-05-12 4 HNSN HANSEN MEDICAL INC
Series E Warrant 		J - Other 2,308,000 2,308,000
2015-05-14 2015-05-12 4 HNSN HANSEN MEDICAL INC
Series E Warrant 		J - Other 3,846,000 3,846,000
2015-05-14 2015-05-12 4 HNSN HANSEN MEDICAL INC
Series E Warrant 		J - Other 12,308,000 12,308,000
2015-05-14 2015-05-12 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share 		P - Purchase 2,361,342 4,928,288 91.99 0.65 1,534,872 3,203,387
2015-05-14 2015-05-12 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share 		P - Purchase 3,934,886 8,543,465 85.38 0.65 2,557,676 5,553,252
2015-05-14 2015-05-12 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share 		P - Purchase 12,592,453 30,906,311 68.76 0.65 8,185,094 20,089,102
2014-12-29 2014-12-23 4 VRML VERMILLION, INC.
Warrants to acquire Common Stock 		P - Purchase 583,333 0 -100.00
2014-12-29 2014-12-23 4 VRML VERMILLION, INC.
Common Stock, Par Value $0.001 per share 		P - Purchase 972,222 8,112,182 13.62 1.44 1,400,000 11,681,542
2014-08-25 2014-08-25 4 HNSN HANSEN MEDICAL INC
Series B/C Exchange Warrant 		X - Other -652,724 0 -100.00
2014-08-25 2014-08-25 4 HNSN HANSEN MEDICAL INC
Series B/C Exchange Warrant 		X - Other -1,171,866 0 -100.00
2014-08-25 2014-08-25 4 HNSN HANSEN MEDICAL INC
Series B/C Exchange Warrant 		X - Other -4,656,852 0 -100.00
2014-08-25 2014-08-25 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share 		X - Other 652,724 2,566,946 34.10 1.13 737,578 2,900,649
2014-08-25 2014-08-25 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share 		X - Other 1,171,866 4,608,579 34.10 1.13 1,324,209 5,207,694
2014-08-25 2014-08-25 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share 		X - Other 4,656,852 18,313,858 34.10 1.13 5,262,243 20,694,660
2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series D Warrant 		J - Other 200,712 200,712
2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series D Warrant 		J - Other 360,350 360,350
2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series D Warrant 		J - Other 1,431,983 1,431,983
2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series B/C Exchange Warrant 		J - Other 652,724 652,724
2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series B/C Exchange Warrant 		J - Other 1,171,866 1,171,866
2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series B/C Exchange Warrant 		J - Other 4,656,852 4,656,852
2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series B Warrant 		J - Other -326,362 0 -100.00
2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series C Warrant 		J - Other -326,362 0 -100.00
2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series B Warrant 		J - Other -585,933 0 -100.00
2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series C Warrant 		J - Other -585,933 0 -100.00
2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series B Warrant 		J - Other -2,382,426 0 -100.00
2014-08-12 2014-08-11 4 HNSN HANSEN MEDICAL INC
Series C Warrant 		J - Other -2,382,426 0 -100.00
2014-02-18 2014-02-14 4 HNSN HANSEN MEDICAL INC
Series A Warrant 		X - Other -326,362 0 -100.00
2014-02-18 2014-02-14 4 HNSN HANSEN MEDICAL INC
Series A Warrant 		X - Other -585,933 0 -100.00
2014-02-18 2014-02-14 4 HNSN HANSEN MEDICAL INC
Series A Warrant 		X - Other -2,328,426 0 -100.00
2014-02-18 2014-02-14 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share 		X - Other 326,362 1,914,222 20.55 1.23 401,425 2,354,493
2014-02-18 2014-02-14 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share 		X - Other 585,933 3,436,713 20.55 1.23 720,698 4,227,157
2014-02-18 2014-02-14 4 HNSN HANSEN MEDICAL INC
Common Stock, par value $0.0001 per share 		X - Other 2,328,426 13,657,006 20.55 1.23 2,863,964 16,798,117
2013-12-23 2013-12-19 4 VRML VERMILLION, INC.
Warrants to acquire Common Stock 		C - Conversion -4,339,980 0 -100.00
2013-12-23 2013-12-19 4 VRML VERMILLION, INC.
Common Stock, par value $0.001 per share 		C - Conversion 4,339,980 7,139,960 155.00
2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Series A Warrant 		P - Purchase 326,362 326,362 0.12 40,795 40,795
2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Series C Warrant 		P - Purchase 326,362 326,362 0.12 40,795 40,795
2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Series A Warrant 		P - Purchase 585,933 585,933 0.12 73,242 73,242
2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Series C Warrant 		P - Purchase 585,933 585,933 0.12 73,242 73,242
2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Series A Warrant 		P - Purchase 2,328,426 2,328,426 0.12 291,053 291,053
2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Series C Warrant 		P - Purchase 2,328,426 2,328,426 0.12 291,053 291,053
2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Series B Warrant 		P - Purchase 326,362 326,362 0.12 40,795 40,795
2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Series B Warrant 		P - Purchase 585,933 585,933 0.12 73,242 73,242
2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Series B Warrant 		P - Purchase 2,328,426 2,328,426 0.12 291,053 291,053
2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Common Stock, par value$0.0001 per share 		P - Purchase 815,904 1,587,860 105.69 1.23 1,003,562 1,953,068
2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Common Stock, par value$0.0001 per share 		P - Purchase 1,464,842 2,850,780 105.69 1.23 1,801,756 3,506,459
2013-08-08 2013-08-08 4 HNSN HANSEN MEDICAL INC
Common Stock, par value$0.0001 per share 		P - Purchase 5,821,064 11,328,580 105.69 1.23 7,159,909 13,934,153
2013-05-23 3 VRML VERMILLION, INC.
Common Stock, par value $0.001 		2,799,980
2008-06-10 3 ACCP ACCESS PHARMACEUTICALS INC
Common Stock, par value $0.01 per share ("Common Stock") 		247,651
2008-06-10 2008-03-11 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock Purchase Warrants 		S - Sale 119,811 119,811
2008-06-10 2008-03-11 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock Purchase Warrants 		P - Purchase 119,811 119,811
2008-06-10 2008-03-11 4 ACCP ACCESS PHARMACEUTICALS INC
Series A Cumulative Convertible Preferred Stock 		S - Sale 72 72
2008-06-10 2008-03-11 4 ACCP ACCESS PHARMACEUTICALS INC
Series A Cumulative Convertible Preferred Stock 		P - Purchase 72 72
2008-06-10 2008-02-12 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock 		S - Sale -29,736 296,483 -9.12 3.15 -93,668 933,921
2008-06-10 2008-02-12 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock 		P - Purchase 29,736 296,483 11.15 3.15 93,668 933,921
2008-06-10 2007-11-10 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock Purchase Warrants 		J - Other 728,850 728,850
2008-06-10 2007-11-10 4 ACCP ACCESS PHARMACEUTICALS INC
Series A Cumulative Convertible Preferred Stock 		J - Other 437 437
2008-06-10 2007-07-24 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock 		S - Sale -2,040 296,483 -0.68 4.35 -8,874 1,289,701
2008-06-10 2007-07-23 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock 		S - Sale -4,000 298,523 -1.32 4.36 -17,425 1,300,456
2008-06-10 2007-06-19 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock 		P - Purchase 60,000 302,523 24.74 5.17 310,200 1,564,044
2008-06-10 2007-06-19 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock 		S - Sale -20,000 302,523 -6.20 5.17 -103,400 1,564,044
2008-06-10 2007-06-19 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock 		S - Sale -40,000 302,523 -11.68 5.17 -206,800 1,564,044
2008-06-10 2007-03-01 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock 		S - Sale -1,200 302,523 -0.40 7.12 -8,550 2,155,476
2008-06-10 2007-02-28 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock 		S - Sale -4,500 302,523 -1.47 7.10 -31,950 2,147,913
2008-06-10 2007-02-28 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock 		S - Sale -10,000 302,523 -3.20 7.10 -71,000 2,147,913
2008-06-10 2007-02-27 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock 		S - Sale -100 318,223 -0.03 7.00 -700 2,227,561
2008-06-10 2007-02-27 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock 		S - Sale -300 318,223 -0.09 7.00 -2,100 2,227,561
2008-06-10 2007-02-26 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock 		S - Sale -1,000 318,623 -0.31 7.31 -7,314 2,330,409
2008-06-10 2007-02-26 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock 		S - Sale -5,000 318,623 -1.55 7.31 -36,570 2,330,409
2008-06-10 2007-02-26 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock 		S - Sale -19,000 318,623 -5.63 7.31 -138,966 2,330,409
2008-06-10 2007-01-22 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock 		P - Purchase 6,040 343,623 1.79 2.53 15,281 869,366
2008-06-10 2007-01-22 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock 		S - Sale -6,040 343,623 -1.73 2.53 -15,281 869,366
2008-06-10 2006-09-01 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock 		S - Sale -0 343,623 0.00
2008-06-10 2006-09-01 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock 		S - Sale -0 343,623 0.00
2008-06-10 2006-09-01 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock 		S - Sale -1 343,623 0.00
2008-06-10 2006-06-05 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock 		J - Other -1,374,497 343,624 -80.00
2008-06-10 2005-12-31 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock 		P - Purchase 78,184 1,718,121 4.77 0.65 50,820 1,116,779
2008-06-10 2005-12-31 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock 		P - Purchase 299,056 1,718,121 21.07 0.65 194,386 1,116,779
2008-06-10 2005-12-31 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock 		P - Purchase 82,745 1,718,121 5.06 0.65 53,784 1,116,779
2008-06-10 2005-12-31 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock 		P - Purchase 15,636 1,718,121 0.92 0.65 10,163 1,116,779
2008-06-10 2005-02-01 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock 		S - Sale -30,200 1,242,500 -2.37 2.69 -81,238 3,342,325
2008-06-10 2005-02-01 4 ACCP ACCESS PHARMACEUTICALS INC
Common Stock, par value $0.01 per share ("Common Stock") 		P - Purchase 30,200 1,242,500 2.49 2.69 81,238 3,342,325
P
非衍生或衍生证券的公开市场或私下买入
S
非衍生或衍生证券的公开市场或私下卖出
A
公司向内部人员授予、奖励或以其他方式获取证券（例如股票期权）
C
衍生工具转换
D
将证券卖出或转让回公司
F
使用从公司收到的证券的一部分来支付行使价或税务负担。
G
内部人士赠送或接收他人赠送公司股票
K
股权掉期和类似的避险交易
M
行使或转换从公司获得的衍生证券（例如期权）
V
内部人士通过Form 4自愿报告的一笔交易
J
其他（附有交易描述的脚注）